Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer
- 1 December 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 63 (5) , 1325-1330
- https://doi.org/10.1016/j.ijrobp.2005.04.030
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Phase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic CancerJournal of Clinical Oncology, 2004
- Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreasJournal of Gastrointestinal Surgery, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic CancerJournal of Clinical Oncology, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 PatientsAnnals of Surgery, 1995
- Neoadjuvant Therapy for Unresectable Pancreatic AdenocarcinomaArchives of Surgery, 1993
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969